Eroglu Z, Kim Y, Gibney G, et al. Mature results of combination nivolumab (NIVO) plus ipilimumab (IPI) as adjuvant therapy in stage IIIC/IV melanoma (MEL). SMR 2017, abstract SMR09-06.
Circulerend tumor-DNA als biomarker bij pancreascarcinoom
sep 2019 | Maag-darm-leveroncologie